UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

BRCA2 and Other DDR Genes in Prostate Cancer

Cancers, 2019-03, Vol.11 (3), p.352

2019

Volltextzugriff (PDF)

NSD2 is a conserved driver of metastatic prostate cancer progression

Nature communications, 2018-12, Vol.9 (1), p.5201-14, Article 5201

2018

Volltextzugriff (PDF)

New perspectives on screening and early detection of endometrial cancer

International journal of cancer, 2019-12, Vol.145 (12), p.3194-3206

2019

Volltextzugriff (PDF)

Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing

Proceedings of the National Academy of Sciences - PNAS, 2011-03, Vol.108 (11), p.4394-4399

2011

Volltextzugriff (PDF)

ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer

Proceedings of the National Academy of Sciences - PNAS, 2013-09, Vol.110 (37), p.E3506-E3515

2013

Volltextzugriff (PDF)

Dual Targeting of the Akt/mTOR Signaling Pathway Inhibits Castration-Resistant Prostate Cancer in a Genetically Engineered Mouse Model

Cancer research (Chicago, Ill.), 2012-09, Vol.72 (17), p.4483-4493

2012

Volltextzugriff (PDF)

Predicting Drug Response in Human Prostate Cancer from Preclinical Analysis of In Vivo Mouse Models

Cell reports (Cambridge), 2015-09, Vol.12 (12), p.2060-2071

2015

Volltextzugriff (PDF)

Stromal interaction molecule 2 (STIM2) is frequently overexpressed in colorectal tumors and confers a tumor cell growth suppressor phenotype

Molecular carcinogenesis, 2012-09, Vol.51 (9), p.746-753

2012

Volltextzugriff (PDF)

A hotspot for posttranslational modifications on the androgen receptor dimer interface drives pathology and anti-androgen resistance

Science advances, 2023-03, Vol.9 (11), p.eade2175-eade2175

2023

Volltextzugriff (PDF)

Epigenetic Regulation in Prostate Cancer Progression

Current molecular biology reports, 2018, Vol.4 (2), p.101-115

2018

Volltextzugriff (PDF)

Chemotherapy in metastatic castration-resistant prostate cancer: Current scenario and future perspectives

Cancer letters, 2021-12, Vol.523, p.162-169

2021

Volltextzugriff (PDF)

Loss of TGFβ signaling increases alternative end-joining DNA repair that sensitizes to genotoxic therapies across cancer types

Science translational medicine, 2021-02, Vol.13 (580)

2021

Volltextzugriff (PDF)

A modular master regulator landscape controls cancer transcriptional identity

Cell, 2021-01, Vol.184 (2), p.334-351.e20

2021

Volltextzugriff (PDF)

Cross-Species Regulatory Network Analysis Identifies a Synergistic Interaction between FOXM1 and CENPF that Drives Prostate Cancer Malignancy

Cancer cell, 2014-05, Vol.25 (5), p.638-651

2014

Volltextzugriff (PDF)

Identification of differential biological activity and synergy between the PARP inhibitor rucaparib and its major metabolite

Cell chemical biology, 2024-05, Vol.31 (5), p.973-988.e4

2024

Volltextzugriff (PDF)

A molecular signature predictive of indolent prostate cancer

Science translational medicine, 2013-09, Vol.5 (202), p.202ra122

2013

Volltextzugriff (PDF)

Editor's Note: Dual Targeting of the Akt/mTOR Signaling Pathway Inhibits Castration-Resistant Prostate Cancer in a Genetically Engineered Mouse Model

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7), p.1160-1160

2023

Volltextzugriff (PDF)

PRL-3 overexpression in epithelial cells is induced by surrounding stromal fibroblasts

Molecular cancer, 2009-07, Vol.8 (1), p.46-46

2009

Volltextzugriff (PDF)

Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment

European urology, 2021-06, Vol.79 (6), p.722-733

2021

Volltextzugriff (PDF)

Abstract B45: Combinatorial activation of PI3-kinase and Ras-Raf signaling in mouse models of advanced prostate cancer

Molecular cancer research, 2014-11, Vol.12 (11_Supplement), p.B45-B45

2014

Volltextzugriff (PDF)

B-Raf Activation Cooperates with PTEN Loss to Drive c-Myc Expression in Advanced Prostate Cancer

Cancer research (Chicago, Ill.), 2012-09, Vol.72 (18), p.4765-4776

2012

Volltextzugriff (PDF)

Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer

PLoS biology, 2011-11, Vol.9 (11), p.e1001199

2011

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Thema

Science & Technology
(25)
Humans
(22)
Life Sciences & Biomedicine
(21)
Animals
(15)
Male
(15)
Mice
(15)
Oncology
(13)
Cell Line, Tumor
(12)
Tumors
(12)
Cancer
(9)
Metastasis
(8)
Prostatic Neoplasms - Genetics
(8)
Cell Biology
(6)
Gene Expression Regulation, Neoplastic
(6)
Prostate Cancer
(6)
Prostatic Neoplasms - Metabolism
(6)
Prostatic Neoplasms - Pathology
(6)
Biochemistry & Molecular Biology
(5)
Disease Models, Animal
(5)
Female
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

BRCA2 and Other DDR Genes in Prostate Cancer

NSD2 is a conserved driver of metastatic prostate cancer progression

New perspectives on screening and early detection of endometrial cancer

Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing

ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer

Dual Targeting of the Akt/mTOR Signaling Pathway Inhibits Castration-Resistant Prostate Cancer in a Genetically Engineered Mouse Model

Predicting Drug Response in Human Prostate Cancer from Preclinical Analysis of In Vivo Mouse Models

Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing Agent

Stromal interaction molecule 2 (STIM2) is frequently overexpressed in colorectal tumors and confers a tumor cell growth suppressor phenotype

A hotspot for posttranslational modifications on the androgen receptor dimer interface drives pathology and anti-androgen resistance

Epigenetic Regulation in Prostate Cancer Progression

An Integrated Approach for the Early Detection of Endometrial and Ovarian Cancers (Screenwide Study): Rationale, Study Design and Pilot Study

Chemotherapy in metastatic castration-resistant prostate cancer: Current scenario and future perspectives

Loss of TGFβ signaling increases alternative end-joining DNA repair that sensitizes to genotoxic therapies across cancer types

A modular master regulator landscape controls cancer transcriptional identity

Cross-Species Regulatory Network Analysis Identifies a Synergistic Interaction between FOXM1 and CENPF that Drives Prostate Cancer Malignancy

Identification of differential biological activity and synergy between the PARP inhibitor rucaparib and its major metabolite

A molecular signature predictive of indolent prostate cancer

Editor's Note: Dual Targeting of the Akt/mTOR Signaling Pathway Inhibits Castration-Resistant Prostate Cancer in a Genetically Engineered Mouse Model

PRL-3 overexpression in epithelial cells is induced by surrounding stromal fibroblasts

Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment

Abstract B45: Combinatorial activation of PI3-kinase and Ras-Raf signaling in mouse models of advanced prostate cancer

DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and Metastasis

B-Raf Activation Cooperates with PTEN Loss to Drive c-Myc Expression in Advanced Prostate Cancer

Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer

Suchergebnisse filtern